Sort   by:  
 Page size 
UnknownPost-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Not available
S-EPMC11381616 | biostudies-literature
UnknownExamination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study.
Not available
S-EPMC6398732 | biostudies-literature
UnknownPulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
Not available
S-EPMC10878386 | biostudies-literature
UnknownSafety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Not available
S-EPMC10150320 | biostudies-literature
UnknownOutpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Not available
S-EPMC11141865 | biostudies-literature
UnknownOutpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Not available
S-EPMC10153328 | biostudies-literature
UnknownAssociation analysis identifies 65 new breast cancer risk loci.
Not available
S-EPMC5798588 | biostudies-literature
UnknownThe Molecular Taxonomy of Primary Prostate Cancer.
Not available
S-EPMC4695400 | biostudies-literature
UnknownA global metagenomic map of urban microbiomes and antimicrobial resistance.
Not available
S-EPMC8238498 | biostudies-literature
UnknownCAMP: a modular metagenomics analysis system for integrated multistep data exploration.
Not available
S-EPMC12809600 | biostudies-literature
Sort   by:  
 Page size